Breen Elizabeth Crabb, Reynolds Sandra M, Cox Christopher, Jacobson Lisa P, Magpantay Larry, Mulder Candice B, Dibben Oliver, Margolick Joseph B, Bream Jay H, Sambrano Elise, Martínez-Maza Otoniel, Sinclair Elizabeth, Borrow Persephone, Landay Alan L, Rinaldo Charles R, Norris Philip J
UCLA Cousins Center for Psychoneuroimmunology, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-7076, USA.
Clin Vaccine Immunol. 2011 Aug;18(8):1229-42. doi: 10.1128/CVI.05032-11. Epub 2011 Jun 22.
The concentrations of cytokines in human serum and plasma can provide valuable information about in vivo immune status, but low concentrations often require high-sensitivity assays to permit detection. The recent development of multiplex assays, which can measure multiple cytokines in one small sample, holds great promise, especially for studies in which limited volumes of stored serum or plasma are available. Four high-sensitivity cytokine multiplex assays on a Luminex (Bio-Rad, BioSource, Linco) or electrochemiluminescence (Meso Scale Discovery) platform were evaluated for their ability to detect circulating concentrations of 13 cytokines, as well as for laboratory and lot variability. Assays were performed in six different laboratories utilizing archived serum from HIV-uninfected and -infected subjects from the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV Study (WIHS) and commercial plasma samples spanning initial HIV viremia. In a majority of serum samples, interleukin-6 (IL-6), IL-8, IL-10, and tumor necrosis factor alpha were detectable with at least three kits, while IL-1β was clearly detected with only one kit. No single multiplex panel detected all cytokines, and there were highly significant differences (P < 0.001) between laboratories and/or lots with all kits. Nevertheless, the kits generally detected similar patterns of cytokine perturbation during primary HIV viremia. This multisite comparison suggests that current multiplex assays vary in their ability to measure serum and/or plasma concentrations of cytokines and may not be sufficiently reproducible for repeated determinations over a long-term study or in multiple laboratories but may be useful for longitudinal studies in which relative, rather than absolute, changes in cytokines are important.
人血清和血浆中细胞因子的浓度能够提供有关体内免疫状态的有价值信息,但低浓度通常需要高灵敏度检测才能实现检测。近期发展起来的多重检测法,可在少量样本中同时检测多种细胞因子,前景广阔,尤其适用于仅有少量储存血清或血浆样本的研究。我们评估了四种基于Luminex(伯乐公司、BioSource公司、Linco公司)或电化学发光(梅索尺度发现公司)平台的高灵敏度细胞因子多重检测法,检测其对13种细胞因子循环浓度的检测能力以及实验室间和批次间的差异。检测在六个不同实验室进行,使用来自多中心艾滋病队列研究(MACS)和女性机构间HIV研究(WIHS)中未感染HIV和感染HIV受试者的存档血清,以及涵盖初次HIV病毒血症阶段的商业血浆样本。在大多数血清样本中,至少有三种试剂盒可检测到白细胞介素-6(IL-6)、IL-8、IL-10和肿瘤坏死因子α,而IL-1β仅能用一种试剂盒清晰检测到。没有一种多重检测板能检测到所有细胞因子,所有试剂盒在不同实验室和/或批次之间均存在高度显著差异(P < 0.001)。尽管如此,这些试剂盒在初次HIV病毒血症期间通常能检测到相似的细胞因子扰动模式。这种多中心比较表明,目前的多重检测法在测量血清和/或血浆中细胞因子浓度的能力上存在差异,对于长期研究或多个实验室的重复测定可能不够可重复,但对于细胞因子相对变化而非绝对变化重要的纵向研究可能有用。